However, a 30% reduction was seen in the composite adverse outcome for foetal and maternal complications (p¼ 0.01).
OBJECTIVE:
The objective of the study was to verify the appearance of signs of suspected Triple I and the progressive involvement of placenta according to Redline classification of chorionamnionitis (CHA) and to understand the impact of CHA on maternal and neonatal outcome STUDY DESIGN: A retrospective cohort study of histological placental analysis obtained after term pregnancies between 2014-2017 at Carate Brianza Hospital, University of Milano-Bicocca. Included were all cases of HCA. The diagnosis of maternal fever (T ) and suspected intraamniotic inflammation, infection or both was made according to Triple I classification (IAI). Maternal adverse outcomes were defined as postpartum haemorrhage, endometritis or composite bad outcome (Mbad) including fever after hospital discharge and/or prolonged antibiotic therapy. Neonatal adverse outcomes were defined as asphyxia, positive blood culture, high CRP or composite bad outcome (Nbad) including admission to NICU and/ or prolonged antibiotic therapy. Histological CHA was stadiated for severity according to Redline classification. Analyses were conducted by SPSSÒ 24.0; p-value <0.05 was considered significant RESULTS: Among 6,962 deliveries, 1,314 placentas of which 1,122 at term, were analysed, 32.4 % due to signs of IAI in labour . 339 of placentas had HCA and 133 (39.2%) of them had a whole inflammatory involvement (PLw). 
The evidence regarding obstetric and neonatal outcomes in trial of labor after cesarean (TOLAC) was established prior to the institution of contemporary labor management. Our objective was to evaluate obstetric and neonatal outcomes in women attempting TOLAC with 2 prior cesareans compared with those with a history of 1 previous cesarean since the advent of a contemporary labor curve. STUDY DESIGN: This was a retrospective cohort study of women attempting vaginal birth after cesarean (VBAC) with 1 and 2 prior cesarean deliveries between January 2011-May 2018 at an academic tertiary care center. Women with viable, non-anomalous singleton gestations were included. The primary outcome was VBAC success. Secondary outcomes were composite maternal and neonatal adverse outcomes ( (Table 2) . CONCLUSION: Women with 2 prior cesareans had lower VBAC success than those with 1 prior cesarean, but most women attempting TOLAC in both groups were successful. Uterine rupture and maternal composite morbidity was similar between women with 2 prior and 1 prior cesarean deliveries, but those with 2 cesareans had Poster Session IV 
